RCS - Sapio Sciences - Oxford Biomedica Deploys Sapio's Laboratory ELN

Oxford BioMedicaAnnouncement

18/07/2023 13:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230718:nRSR2731Ga&default-theme=true

RNS Number : 2731G  Sapio Sciences  18 July 2023

Oxford Biomedica Implements Sapio Sciences' Electronic Laboratory Notebook

Sapio's No-Code ELN to Provide Enhanced Collaboration, Unified Data Access,
and Flexible Workflows to viral vector CDMO Oxford Biomedica

BALTIMORE, MD / ACCESSWIRE / July 18, 2023 / Oxford Biomedica (OXB), a quality
and innovation-led viral vector CDMO, has implemented Sapio's Electronic
Laboratory Notebook
(https://stats.newswire.com/x/html?final=aHR0cHM6Ly93d3cuc2FwaW9zY2llbmNlcy5jb20vcHJvZHVjdHMvZWxlY3Ryb25pYy1sYWItbm90ZWJvb2sv&sig=T9IOwSPAj2C6Hm3uVqFlJ6Ap7vWn0hjubHUEpJuPNmnu0qV-YcJ9O1QSGtcGS4Sy_37EZhXgBFXHO_w4wIfEOw&hit%2Csum=WyIzeWprNnoiLCIzeWprNzAiLCIzeWprNzEiXQ)
(ELN) as part of its digital transformation. The integration of Sapio's ELN is
set to increase efficiency of completing tasks, and bolster the insight gained
from the state-of-the-art technologies developed at OXB.

"Sapio's configurable no-code/low-code ELN platform will help to facilitate
our digital transformation at OXB, supporting us to deliver high-quality viral
vector CDMO services to our clients," said Matthew Treagus, Chief Information
Officer at Oxford Biomedica.

"We are thrilled to partner with Oxford Biomedica, a front-runner in the realm
of gene and cell therapy," said Kevin Cramer, CEO and Founder of Sapio
Sciences. "Sapio's Electronic Laboratory Notebook (ELN) software is built to
revolutionize lab work. We are excited to see how Sapio's ELN can help OXB to
drive efficiency and deliver quality services to their clients."

About Sapio Sciences

Sapio Sciences' mission is to improve life in the lab - because science is
complex, Sapio makes technology simple. Sapio is a global business offering an
all-in-one science-aware(TM) lab informatics platform combining cloud-based
LIMS, ELN, and Jarvis data solutions.

Sapio serves some of the largest global and niche brands, including biopharma,
CRO's and clinical diagnostic labs across NGS genomic sequencing, bioanalysis,
bioprocessing, stability, clinical, histopathology, drug research, and in vivo
studies.

Customers love Sapio's platform because it is robust, scalable, and with
no-code configuration, can quickly adapt to meet unique needs. For more
information visit www.sapiosciences.com
(https://stats.newswire.com/x/html?final=aHR0cHM6Ly93d3cuc2FwaW9zY2llbmNlcy5jb20&sig=D-vdThcbtJh3ncNWj-VnZRcBgjpWvoOjtB9z350_aePqZWzLV30so03f6PZ3xYPA-KeL7aA8bY_I5OucsfkPJw&hit%2Csum=WyIzeWprNzIiLCIzeWprNzMiLCIzeWprNzEiXQ)
and follow us on LinkedIn here
(https://stats.newswire.com/x/html?final=aHR0cHM6Ly93d3cubGlua2VkaW4uY29tL2NvbXBhbnkvc2FwaW8tc2NpZW5jZXMtbGxjLw&sig=6qLzYWMkp_cy8UcfHVlecFPErQBRe2dHSD7gCUZh-YuveDughZeLHDFNMXvx4v_gOyNk8QEKi_-2sZFAh-cwew&hit%2Csum=WyIzeWprNzQiLCIzeWprNzUiLCIzeWprNzEiXQ)
.

Contact Information

Richard Halton

Vice President Global Marketing
marketing@sapiosciences.com (mailto:marketing@sapiosciences.com)

+14108004620

SOURCE: Sapio Sciences

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAUBAVROVUBAAR